Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- 31 October 2011
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 141 (4), 1194-1201
- https://doi.org/10.1053/j.gastro.2011.06.054
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or InfliximabGastroenterology, 2009
- Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based CohortGastroenterology, 2007
- Inflammatory bowel disease: clinical aspects and established and evolving therapiesThe Lancet, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practiceClinical Gastroenterology and Hepatology, 2004
- Medical therapy for ulcerative colitis 2004Gastroenterology, 2004
- Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitisGastroenterology, 2001
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyThe New England Journal of Medicine, 1994
- Microscopic activity in ulcerative colitis: what does it mean?Gut, 1991
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987